A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry ...

US pharma giant Pfizer (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the ...

California, USA-based biotech Cytokinetics saw its shares fall as much as 4% to $9.67 yesterday, after it announced a deal ...

Samsung Biologics has secured a $668 million manufacturing agreement with a European pharma, bringing its total deals for the ...

The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) ...

Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). A ...

The UK’s health technology assessor the Institute for Health and Clinical Excellence (NICE) says that talks with the makers ...

Johnson & Johnson and Protagonist Therapeutics announced positive Phase III results for icotrokinra, an oral IL-23 targeting ...

Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA).

US pharma giant Merck & Co (NYSE: MRK) today announced positive top-line results from the pivotal Phase III MK-3475A-D77 ...

The company is confident that it is on to something special with its novel anti-growth differentiation factor-15 (GDF-15) ...

UK pharma major GSK today announced positive headline results of GLISTEN, the ongoing global Phase III clinical trial ...